Abaloparatide
Class
Osteoanabolic agents
Subclass
Parathyroid hormone-related protein analogs
Substance name
Abaloparatide
Brand names
Tymlos®
Common formulations
Solution for injection
Dosage and administration
Adults patients
Osteoporosis in males with high risk for fractures
Osteoporosis in postmenopausal females with high risk for fractures
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
Hypersensitivity to abaloparatide or its components
High risk for osteosarcoma
Hypercalcemia
Warnings and precautions
Exacerbation of urolithiasis
Orthostatic hypotension
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters
Breastfeeding
Not intended for use in females of childbearing potential.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource